CD8A and myeloid sarcoma: In contrast to elderly patients, this aberration was notably evidenced in young MS patients, especially in patients with PPMS, implying a trend of premature immune aging in the CD8+ T cell compartment of young MS patients, with possible consequences for clinical outcomes [155].